Switzerland· 50496023

Livostin Augentropfen, Augentropfensuspension

A levocabastine product containing levocabastinum, registered in Switzerland by JNTL Consumer Health II (Switzerland) GmbH and dispensed under Swissmedic category D, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat D (Swissmedic)ATC S01GX02

Checked against Swissmedic (Switzerland) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about levocabastinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Levocabastine is registered in 9 of 19 countries.

Countries holding a registration under ATC S01GX02 (levocabastine), each read from that country’s own register.

This record: Switzerland, from Swissmedic (Switzerland)
6 of them publish a price we can compare per daily dose

Search levocabastine products by name

Levocabastine · ATC S01GX02

9 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Icelandprice
Netherlands
Norwayprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)

Active substance: levocabastinum
Manufacturer: JNTL Consumer Health II (Switzerland) GmbH
Country: Switzerland (CH)
ATC code: S01GX02
ATC class: Levocabastine
Swissmedic category: D
Reimbursed: Yes
Source register: Swissmedic (Switzerland)
Last checked: September 12, 2026

Packs & prices · 1

1 priced

gtin
7680504960234
4 ml
CHF 12.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Levocabastine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levocabastine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

Austria · Levocamed, Livostin
Belgium · Livostin, Nasasinuspray Anti-Allergie
Czechia · Livostin
Germany · Levocabastin, Levocamed
Denmark · Benaliv
Spain · Bilina, Reactine
Finland · Livostin
France · Allergiflash, Levofree
Greece · Livostin
Iceland · Livostin
Italy · Levoreact, Levoreact Oftalmico
Luxembourg · Livostin, Nasasinuspray Anti-Allergie
Netherlands · Livocab
Norway · Livostin
Sweden · Livostin
Slovakia · Livostin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/da93e4ab-7bfc-4ee4-85a9-cc28b3b62e2a
GET /v1/drugs/da93e4ab-7bfc-4ee4-85a9-cc28b3b62e2a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "levocabastinum 0.5 mg",
  "valid_from": "1992-03-15",
  "limitations": null,
  "galenic_form": "Gtt Opht 0.5 mg/ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "1992-03-15",
  "self_retention_pct": 10
}

API reference MCP server Plans

See everything about levocabastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console